BEFORE YOU START A GLP-1: 10 Questions Worth Asking Before the First Dose

SOULSPRING WELLNESS JOURNAL™

Volume One • Issue 02

There is no shortage of conversation around GLP-1 medications.

How much weight will I lose?

How quickly will I lose it?

Which medication should I take?

Those questions are understandable. But they are only part of the conversation.

Because GLP-1 medications do more than influence appetite. They affect several physiological pathways, including satiety, blood glucose regulation, and gastric emptying. Slowing gastric emptying can contribute to feeling fuller sooner and eating less. Gastrointestinal side effects are also among the most common effects reported with these medications.

That means starting a GLP-1 deserves more thought than simply deciding whether you want to lose weight.

It deserves a conversation about digestion.

Nutrition.

Muscle.

Bowel regularity.

Side effects.

Long-term treatment.

And what happens if you eventually stop taking it.

So before the first dose, here are 10 questions worth asking.

1) What happens to my digestion when gastric emptying slows?

This is one of the most important pieces of the GLP-1 conversation, and it is something we introduced in Issue 01.

Let’s take a closer look.

Gastric emptying is the process of food moving from your stomach into your small intestine. GLP-1 receptor agonists can slow this process, which contributes to the feeling of fullness and reduced food intake associated with these medications.

For some people, that change is manageable and may be part of the desired therapeutic effect.

For others, changes in gastrointestinal function can be uncomfortable.

Nausea, vomiting, diarrhea, constipation, abdominal discomfort, bloating, indigestion, and reflux have all been reported with GLP-1 medications. Gastrointestinal adverse reactions are among the most frequently reported effects with semaglutide, particularly during dose escalation.

This is why understanding gastric emptying matters.

The question isn’t simply:

“Will this medication make me less hungry?”

It is also:

“How will my digestive system respond when my appetite and the movement of food through my stomach change?”

That is a conversation worth having before you begin.

2) If my appetite decreases significantly, how will I meet my nutritional needs?

One of the intended effects of GLP-1 therapy can be a substantial reduction in appetite.

That can be helpful for someone who has struggled with hunger, cravings, or difficulty maintaining a calorie deficit.

But eating less also means there may be less room for nutritional error.

If your overall food intake decreases significantly, the quality and nutrient density of the food you do eat become increasingly important.

Protein.

Fiber.

Fluids.

Vitamins and minerals.

Adequate overall nutrition.

These are not details to think about after you’ve lost the weight.

They are part of the process.

And if eating becomes difficult because of nausea, early fullness, or other gastrointestinal symptoms, it is worth discussing with your healthcare provider or a qualified nutrition professional how to maintain adequate nutrition while taking the medication.

The goal should never be simply to see how little you can eat.

The goal is to support your body while your appetite and food intake are changing.

3) What should I know about constipation and elimination?

We often think about appetite first.

But the other end of the digestive process matters too.

Changes in gastrointestinal motility can affect bowel habits, and constipation is a recognized gastrointestinal adverse effect of GLP-1 medications.

Before starting a GLP-1, it is worth knowing what is normal for your body.

How often do you typically have a bowel movement?

Are you already dealing with constipation?

Are you drinking enough fluids?

Are you getting adequate fiber?

Are you moving your body regularly?

And do you know what symptoms should prompt a conversation with your healthcare provider?

Digestive regularity is part of the bigger picture.

4) Which side effects are common, and which ones are serious?

This distinction matters.

Many people experience gastrointestinal symptoms with GLP-1 therapy, particularly during dose escalation.

For example, nausea, diarrhea, vomiting, and constipation are among the gastrointestinal adverse reactions reported with semaglutide.

But there are also less common, potentially serious adverse reactions and warnings that patients should understand.

Current FDA prescribing information includes warnings related to acute pancreatitis, acute gallbladder disease, acute kidney injury associated with volume depletion, severe gastrointestinal adverse reactions, and serious hypersensitivity reactions.

This is not meant to create fear.

It is meant to create awareness.

Before starting a medication, you should know what symptoms may be expected, what symptoms deserve a call to your healthcare provider, and what symptoms require urgent medical attention.

An informed patient is an empowered patient.

5) How will I protect my muscle while losing weight?

This is a conversation that deserves much more attention.

The scale tells you how much you weigh.

It does not tell you exactly what that weight represents.

When someone loses a significant amount of weight, changes can occur in both fat mass and lean mass. Research on semaglutide has demonstrated reductions in lean body mass alongside overall weight loss, while the proportion of lean mass relative to total body weight increased.

A 2026 review in the New England Journal of Medicine identifies loss of muscle and bone mass as areas that deserve continued attention as GLP-1 therapies are used more broadly.

So before starting, ask:

How will I protect my strength?

That may include adequate protein intake, resistance training, appropriate physical activity, and individualized nutrition guidance.

The goal isn’t simply to become smaller.

It is to support a strong, functional body.

6) What does my health history change about this decision?

There is no universal answer to whether a GLP-1 medication is appropriate for a particular person.

Your medical history matters.

So do your current medications, previous gastrointestinal problems, metabolic health, surgical history, and other individual risk factors.

Some people may have conditions that require additional consideration or monitoring.

For example, current FDA prescribing information for Wegovy states that the medication is not recommended in patients with severe gastroparesis.

This is one reason a medication decision should be individualized rather than based on what worked for a friend, a celebrity, or someone you follow online.

Before you start, make sure the person prescribing the medication understands your complete health history and current medications.

7) Am I prepared for the possibility that this could be long-term treatment?

It is easy to focus on the first few months.

The first dose.

The first five pounds.

The first change in clothing size.

But what happens after six months?

A year?

Several years?

How long might treatment continue?

What monitoring will you need?

What will maintaining your progress look like?

These are important questions because GLP-1 therapies may be used as ongoing treatment rather than simply as a short-term intervention.

The long-term picture is still evolving, including questions around adherence and what happens when treatment is discontinued.

Thinking about the destination before you start the journey can help you make a more informed decision.

8) What happens if I stop taking it?

This may be one of the most overlooked questions to ask before starting.

It is important to understand what may happen when the medication is removed.

GLP-1 medications can influence appetite and satiety while you are taking them. When treatment is discontinued, those effects may diminish.

Research has documented weight regain after discontinuation of GLP-1-based therapies, although the degree varies among individuals and depends on the medication, duration of treatment, and other factors.

The question of weight regain after discontinuation remains an important area of ongoing research.

So ask your healthcare provider:

“If I eventually stop this medication, what is the plan?”

And perhaps even more importantly:

“What foundations can I build while I’m taking it that will continue to support me afterward?”

9) What will I do differently while taking the medication?

This question brings the conversation beyond the medication itself.

If a GLP-1 reduces appetite, what will you do with that opportunity?

How will you nourish yourself?

How will you maintain strength?

How will you move your body?

How will you support hydration?

How will you pay attention to digestion and elimination?

How will you build habits that support your health whether or not you remain on medication?

Medication can be one part of a larger health strategy.

It doesn’t have to be the entire strategy.

The more intentional you are about the rest of your health while taking the medication, the more information you may have about what actually supports your wellbeing.

10) What does success actually mean to me?

Maybe this is the biggest question of all.

Is success a number on the scale?

Or is it also:

More strength.

More energy.

Better metabolic health.

Adequate nutrition.

Comfortable digestion.

Regular elimination.

Better mobility.

Improved physical function.

A sustainable relationship with food.

Greater confidence in your body.

A life that feels better to live.

Weight loss can absolutely be an important outcome.

But it does not have to be the entire definition of health.

BEFORE YOU START, PAUSE.

There is nothing wrong with wanting to lose weight.

There is nothing wrong with considering medication.

And there is nothing wrong with having questions.

In fact, questions are exactly what we need more of.

GLP-1 medications have changed the landscape of obesity and metabolic health, and the evidence continues to evolve. We are learning more about their benefits, their risks, their long-term use, and the ways they affect the body.

That is why the conversation doesn’t need to be polarized.

It can be thoughtful.

It can be nuanced.

It can include both medical treatment and whole-person health.

Before the first dose, ask questions.

Understand the medication.

Understand your own health history.

Understand what you may need to monitor.

And think beyond the scale.

Because an informed decision is more than knowing what a medication might do to your weight.

It is understanding what may be happening throughout your body and considering how you want to support your health along the way.

THE SOULSPRING PERSPECTIVE

At SoulSpring Oasis, we believe health is more than a number.

It is how you nourish yourself.

How you move.

How you digest.

How you eliminate.

How you sleep.

How you build strength.

How you care for your body through change.

And how you stay connected to what your body is communicating.

There is room for medical care.

There is room for evidence-based treatment.

And there is room for supportive daily practices that help you care for the whole person.

The goal of this series isn’t to tell you whether you should or shouldn’t take a GLP-1.

The goal is to help you ask better questions.

Because informed choices begin with understanding.

Evidence over hype.

Education over fear.

Curiosity over judgment.

SOURCES

Rosen CJ, Ingelfinger JR.
“GLP-1 Receptor Agonists.”
New England Journal of Medicine. 2026;394:1313–1324. Published April 1, 2026.
https://www.nejm.org/doi/full/10.1056/NEJMra2500106

U.S. Food & Drug Administration.
“Wegovy (semaglutide) Prescribing Information.”
U.S. Food and Drug Administration. 2025.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218316Orig1s000lbl.pdf

Wilding JPH, Batterham RL, Calanna S, et al.
“Once-Weekly Semaglutide in Adults with Overweight or Obesity.”
New England Journal of Medicine. 2021;384:989–1002.
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

A NOTE FROM SOULSPRING

Thank you for joining us for Volume One • Issue 02 of the SoulSpring Wellness Journal.

Our intention with this series is to create a thoughtful space for conversations about health and wellness, grounded in evidence, curiosity, and compassion.

We will continue exploring this topic from different angles, taking a closer look at the research, the questions worth asking, and the ways these conversations connect to whole-body wellness.

Stay curious. Stay connected to your body. And keep asking good questions.

Until next time,

SoulSpring Oasis

Important note: This article is for educational purposes only and is not medical advice or a substitute for individualized care. GLP-1 medications should be prescribed and monitored by a qualified healthcare professional. If you are considering starting, changing, or stopping a medication, discuss your individual circumstances, risks, and benefits with your healthcare provider.